1
/
of
0
FDA Drug Approval, N019030, BRETYLIUM TOSYLATE
FDA Drug Approval, N019030, BRETYLIUM TOSYLATE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 019030
Company: HOSPIRA
Drug Name: BRETYLIUM TOSYLATE
Active Ingredients: BRETYLIUM TOSYLATE
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD
Company: HOSPIRA
Drug Name: BRETYLIUM TOSYLATE
Active Ingredients: BRETYLIUM TOSYLATE
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details